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Abstract
Background
With further expansion of the number of conditions for which 
newborn screening can be undertaken, it is timely to consider the 
impact of positive screening results and the confirmatory testing 
period on the families involved. This study was undertaken as part of 
a larger programme of work to evaluate the Expanded Newborn 
Screening (ENBS) programme in the United Kingdom (UK). It was 
aimed to determine the views and experiences of healthcare 
professionals (HCPs) and parents on communication and interaction 
during the period of confirmatory testing following a positive 
screening result.
Methods
Semi-structured interviews were undertaken with parents of children 
who had received a positive ENBS result and HCPs who had been 
involved with the diagnosis and support of parents. Ten parents and 
11 healthcare professionals took part in the in-depth interviews. 
Questions considered the journey from the positive screening result 
through confirmatory testing to a confirmed diagnosis and the 
communication and interaction between the parents and HCPs that 
they had been experienced. Key themes were identified through 
thematic analysis.
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Results
The results point to a number of elements within the path through 
confirmatory testing that are difficult for parents and could be further 
developed to improve the experience. These include the way in which 
the results are communicated to parents, rapid turnaround of results, 
offering a consistent approach, exploring interventions to support 
family relationships and reviewing the workload and scheduling 
implications for healthcare professionals.
Conclusions
As technology enables newborn screening of a larger number of 
conditions, there is an increasing need to consider and mediate the 
potentially negative effects on families. The findings from this study 
point to a number of elements within the path through confirmatory 
testing that are difficult for parents and could be further developed to 
benefit the family experience.
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Background
The advantages of newborn screening (NBS) in terms of early detection 
and treatment of serious conditions are well-documented [1, 2, 3]. Until 
recently in the UK routine newborn screening (NBS) was undertaken 
for five conditions Sickle cell disease, Cystic Fibrosis, Congenital 
Hypothyroidism, Phenylketonuria and Medium-Chain Acyl-CoA 
Dehydrogenase Deficiency (MCADD) [4]. In 2012 Expanded newborn 
screening (ENBS) for five additional inherited metabolic diseases 
(IMDs) was introduced as a pilot programme for Maple Syrup Urine 
Disease (MSUD), Homocystinuria (pyridoxine unresponsive) (HCU), 
Isovaleric Acidaemia (IVA), Glutaric Aciduria Type 1 (GA1) and Long 
Chain Hydroxyl Acyl CoA Dehydrogenase Deficiency (LCHADD) at 
six centres in England [4, 5, 6]. From 2015, the UK National Screening 
Committee adopted screening for four of the five additional conditions 
(HCU, MSUD, GA1 and IVA) within the UK NBS programme.
With the expansion of screening programmes to include additional rare 
conditions, there is a need to further consider, and minimise the impact 
on families where possible [7, 8]. Expanded screening will increase the 
identifications of conditions (true positives), but also result in an 
increase in the number of false positive results where an initial out of 
range screening result for a condition is followed by confirmatory 
testing that indicates the disorder is not present [8, 9, 10, 11]. This 
lower positive predictive value associated with a screen positive test 
result is characteristic of some of the newer candidate disorders. 
Whether a condition is found to be present, the period of confirmatory 
testing can cause significant anxiety for the families concerned as they 
wait for results [12, 13, 14]. Research has indicated an impact on family 
relationships, parental depression and ongoing relationships with health 
care professionals (HCPs) [15, 16]. The communication and support 
provided during the confirmatory testing period are thought to mediate 
the impact on the family [9, 13, 17, 18, 19, 20].
Guidelines exist to guide the communication of screening results [16, 
21, 22] but implementation is believed to vary in practise and further 
exploration of parental and clinician views is warranted. Existing 
research on communication in this context has been conducted mainly 
in the USA and findings cannot be directly applied to the UK where 
screening is designed as a community based activity with an emphasis 
on integrated care during the maternity pathway [23].
The study described here was undertaken as part of a larger programme 
of work to evaluate the ENBS pilot in the UK. ENBS pilot studies have 
tended to report on the performance of the service (e.g. screen-positive 
prevalence and predictive value, screening uptake) [24, 25, 26] with 
limited exploration of communication and the parental and clinician 
experience during the pilot. Here it was aimed specifically to determine 
the views and experiences of healthcare professionals (HCPs) and 
parents on communication and interaction during the period of 
confirmatory testing following a positive screening result.
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Methods
Semi-structured interviews were undertaken with parents of children 
who had received a positive ENBS result and HCPs who had been 
involved with the diagnosis and support of parents during the pilot 
period (July 2012–July 2013). The study was approved by the National 
Research Ethics Service (East Midlands committee, Northampton, UK). 
All participants gave their written informed consent prior to 
participation in the study.
Recruitment and participants
The ENBS program involved screening across six centres in the UK: 
Sheffield Children’s NHS Foundation Trust, Leeds, Great Ormond 
Street Hospital, Manchester Children’s Hospital, Birmingham 
 
Children’s Hospital and Guy’s and St Thomas’ NHS Foundation Trust. 
Inclusion criteria for the HCP sample stated that Metabolic Physicians, 
Specialist Metabolic Nurses, and Specialist Metabolic Dieticians 
involved in the ENBS pilot with experience of communicating 
screening results to parents would be invited to take part. A key factor 
for inclusion was availability for interview, as getting busy clinical staff 
for interview was an issue, and therefore there was an element of 
opportunity involved. Eleven semi-structured interviews were 
conducted with six metabolic physicians, two nurses and three 
dieticians. This represented at least one member of staff from each of 
the six screening centres.
The parental sample included mothers and fathers who received a true 
or a false positive ENBS result and were able to give informed consent. 
Parents under 16 or unable to give informed consent were excluded. 
During the ENBS pilot there were total of 30 screen positives (12 false 
positives and 18 true positive). They were asked by the NHS Trusts 
whether they would consent to being contacted about related research. 
Seventeen provided consent to be contacted about the study; nine of 
these were successfully contacted by telephone and agreed to take part. 
To improve recruitment, the sample was later widened to include those 
who were screened for these conditions while screening was extended 
and one additional participant recruited.
Ten parents took part; two interviews were undertaken as paired 
interviews with both the father and mother present. Two participants 
were recruited through Great Ormond Street, one from Sheffield, one 
from Leeds and six from Birmingham. The conditions for which they 
screened positive, and time elapsed between the screening result and the 
interview are indicated in Table 1. The parents and HCPs involved were 
not matched in this study; whilst the screening centre for each parental 
participant was recorded, the HCPs involved in the process were not.
Table 1
Summary of participant demographics
Gender of participant Age of child at interview Condition True (TP) or false positive (FP) screen
Male 21 months GA1 TP
Gender of participant Age of child at interview Condition True (TP) or false positive (FP) screen
Female 24 months GA1 TP
Female 9 months GA1 TP
Female 23 months IVA FP –diagnosis of benign condition
Female 17 months HCU FP –equivocal results
Female 24 months MSUD TP
FemaleMale 24 month IVA TP
MaleFemale 14 months HCU TP
Eight participants’ children had a true positive screen. Two were 
identified as false positive cases; however further testing led to a 
diagnosis of a benign condition in one case, and equivocal results for 
the other as reported by the parents at the time of the interview. Four 
out of the five ENBS conditions were represented. The children ranged 
from being healthy, managed through diet, to having been very sick at 
discrete episodes.
Procedure
The semi-structured interview schedules were developed through 
consultation with the project team (see additional files for interview 
schedules). For the HCPs, questions probed experiences of giving 
screening results, parental responses to the news, and their 
recommendations regarding communication. The differences in 
approach taken to parents suspected of having a true versus a false 
positive screening result were explored. Questions for the parents 
considered their journey from the positive screening result through 
confirmatory testing to a confirmed diagnosis and the communication 
and interaction with HCPs that they experienced. Whilst the approach 
offered some structure, it was possible to discuss issues as they were 
raised by participants.
The interviews were undertaken by three experienced researchers from 
Coventry University who have conducted many interviews within a 
healthcare context. They were unknown to the participants. The 
participants were briefed on the purpose of the interview and the 
researchers motivation to improve family experiences when the 
interviews were arranged. The HCP interviews were either undertaken 
face to face at the NHS Trust sites, or on the telephone to suit the 
requirements of the participants. The interviews lasted 30–60-min. The 
interviews with parents lasted 20–60 min and took place in the homes 
of the parents or over the telephone to suit the participant. Two 
interviews involved the parents being interviewed together. Typically a 
young child was present too. One interview was undertaken in a 
combination of Urdu and Punjabi, and another in Arabic, these were 
translated during transcription.
Analysis
The interviews were recorded, transcribed verbatim and analysed 
independently by two researchers using thematic content analysis to 
identify patterns within the data [27]. Transcripts were coded line by 
line to identify relevant aspects of the data, once a comprehensive set of 
codes had been identified; repeated patterns across the data set were 
identified to generate themes. These themes were then reviewed, refined 
and illustrative quotations selected.
Results
HCP and parent viewpoints have been synthesised together in 
identifying key themes and emerging recommendations summarised in 
Table 2.
Table 2
Recommendations for improving communication and interaction
A summary of emerging recommendations and areas for future research
Pre-screening• Awareness raising of the ENBS conditions amongst parents, the public and wider HCP community.
Initial contact
• Development of exemplar communication scripts for the first call to parents to relay screening results and / or arrange an appointment; co-design of content with parents and HCPs.• Ensure direct contact between a specialist and the family the same day the parents are notified of the positive screening result• Ensure access to advice and support during the period spent waiting for a meeting with a specialist.• Development of information related to true and false positive results to be received by parents at the point of an initial screening result being relayed; co-design of content with parents and HCPs.• Ensure the availability of a neutral translator for relaying the information to parents whose first language is not English.
Waiting for a confirmatory diagnosis• Rapid turnaround of confirmatory results, ensuring that accurate timeframes are given to the parents.• Ensure access to support systems during the waiting period.• Provision of clear, actionable information in verbal, written and online mobile formats that can be easily shared.• Provide clear guidance and maternal support around breastfeeding.• Encourage personal support from a friend or wider family especially if there is only one parent available.
Long-term support• Ensure availability and referral to psychological support where required once a diagnosis is reached.• Development of a toolkit that provides condition specific information for non-specialist clinicians to provide support to families from the screening test onwards.• Development of an online self-management resource for parents that provides condition specific information and support for parents from screening through to ongoing condition management.
System support mechanisms• Consider how a consistent approach and service can be offered to support families and embed evidence-based guidelines whilst taking into account local context and resources.• Review the resource implications of screen positives and conditions identified through screening, to make recommendations regarding resource allocation.• Consideration of adaptable workload models and scheduling to cater for the management of screen positive cases whilst minimising the impact on the HCPs involved.
Future research• Explore factors affecting diagnostic acceptance and how these factors can be affected by clinical interactions.• Explore psychological interventions to support family relationships whilst managing a child with a long-term condition.
Pre-screening information
Parents recalled consenting to take part in the ENBS pilot programme 
[6] but felt they had little or no knowledge of the ENBS condition with 
which their child received a positive screen:
“He’s got a condition that we’ve not heard of before” 
(P1: L230).
Parents had little recollection of pre-screening information and 
indicated there was a need for more general awareness of the 
conditions. They reported that they had not expected to hear back 
following the ‘heel-prick’ and so felt unprepared for the result. HCPs 
agreed that in their experience, parents typically had not heard of the 
ENBS conditions and were unfamiliar with the available pre-screening 
information.
Initial contact
The first contact between the parent and an HCP to relay the screening 
result left a strong lasting memory with parents. Contact was made by 
telephone either to arrange a home visit by the midwife or a nurse, or to 
ask the parents to go into the hospital (with variations per area). The 
anxiety and long term memory of this initial call was recognised by 
both parents and HCPs:
“..the very first phone call that they receive, that 
information of a positive and there could be something, 
that is the one that remains with them, how that has been 
dealt with, how it’s been communicated, that is the 
important one” (HCP5: L46–8).
“It just sends you into panic……It makes you feel really 
sick doesn’t it (P7: L448–451).
Parents recommended that the initial phone call needed to provide ‘the 
right amount of information’ but the quantity and content was difficult 
to define:
“I think when they ring you up they should explain like 
what is it, they should tell you straight on the phone 
why, because why should you be worried and getting 
stressed, crying because, or your baby might die, or it 
might be serious..” (P3: L116–119).
“I would try and avoid if it was me. I would try and 
avoid giving away too much detail until you’re in a 
position sat talking to these people where you can 
explain a lot more fully rather than just this horrible tit-
bit of information.” (HCP8 L466–469).
This initial contact was perceived to affect anxiety during the first face 
to face meeting with the consultant specialist. There was agreement 
between parents and HCPs that further consideration of the best way to 
make contact with parents would be beneficial.
In some regions a screening or metabolic nurse was able to go out to the 
family with the midwife to relay the news of the positive screening 
result providing a familiar HCP and a subject specialist, but was not 
always possible due to resource limitations. It was agreed that direct 
contact between the HCP and family the same day was important. The 
reported time between the phone call and direct contact with the 
specialist team varied from about 15 min to 2 days. Parents felt, where 
there was a delay some contact was needed with a knowledgeable 
professional:
“… I suppose if somebody had come round and sat down 
with us to try and keep us a bit calmer cos to have a few 
minute phone call and then put the phone down and sent 
an email you think Jesus Christ this is awful” (P2: L226
–229).
First consultation
The initial consultation between the parents, the metabolic specialist 
and their team was typically a long meeting, lasting 1 to 4 h. Typically 
a multi-professional team approach (including a registrar, a screening 
and or metabolic nurse and dietician) was taken to facilitate parental 
and HCP understanding.
HCPs indicated that they give core information about the condition and 
testing process, and then tailor their approach and further information to 
the family needs and understanding. The conditions are rare, hard to 
understand and usually unknown to the parents:
“..the conditions they’re not names that people are 
familiar with. I had one parent say to me ‘You know if 
you told me it was down-syndrome I could understand’, 
so we then have the other problem of this huge strange 
name that people can’t even pronounce, so I kind of 
break it down to things, sizeable information bits that 
they can comprehend and then tell them not to bother 
with this huge name but that’s what it means.” (P5: 
L113–8).
Some parents were reported by HCPs to take the news badlytake the 
news badlyfind the news of the screening result very difficult, or not 
take it in. In general, parents indicated that at this time they had tended 
to focus on the future, the worst case scenario, and the implications of 
the condition and wanted an accurate assessment of the likely reality:
“I just wanted to know for my child what is going to 
happen to her…“(P2:L160).
Parents recalled being given an indication of the likely diagnosis at this 
stage:
“…they said the heel prick was really high so it’s more 
than likely that he’s got it “(P3 L284–5).
“Within half an hour of speaking to us they had kind 
of…they only told us that something might be horribly 
wrong but also put our minds at rest by saying it’s odd 
that you know they would have expected to see 
symptoms” (P8: L58–60).
HCPS were asked if they adapted their style if they suspected a 
diagnosis would be reached from the positive screening result. The 
majority of the metabolic consultants felt they would adapt their 
communication style if the screening marker levels strongly indicated a 
true or false positive to minimise parental anxiety:
“Now, normally you’ve got some inkling of which 
direction this is going to be, so again, you should have 
tried to prepare them for the result you think you’re 
going to get. And you know, 90% of the time you’re 
probably fairly accurate in that (P6: L152–4).
Some cases were considered easy to clarify (for example premature or 
ill babies), and were managed in such a way to avoid causing too much 
anxiety. More confidence in the likely outcome evolved over the ENBS 
pilot.
Typically (as reported by parents and the HCPs) both the mother and 
father were able to attend the appointments, and sometimes an 
additional family member too. HCPs believed that it was preferable for 
the parent to have someone else present for emotional support, to 
inform discussions about the parental history for inherited conditions, 
and ensure the family has the knowledge to manage the child. However, 
it was also noted that it can be difficult if there are too many people in 
the room (including HCPs, family and interpreters):
“my concern is getting the balance right between too 
many people in the room because that can actually be 
difficult sometimes, it’s a bit overwhelming for 
parents...” (HCP8 L287–9).
The HCPs and parents agreed that the first face to face contact and 
consultation with a specialist led to reassurance:
“So most parents will cry at the end of the clinic or 
afterwards when they’re with the nurses or dieticians, 
but actually they normally leave feeling much better than 
they did when they came”.(HCP6 L85–7).
“Once we got to the hospital they were knowledgeable 
and professional – just the wait and initial call not 
good” (P7 L497).
However, it was recognised by a number of parents that they were too 
anxious during the first consultation to take in all of the information 
given:
“Yeah probably just you know all little charts and things 
what does that mean and what’s this and genes are 
missing here and I don’t know, I don’t know what you’re 
talking about and at the time I can’t process because I’m 
just worried and upset for my baby and yeah it’s too 
much”. (P2 L175–8).
The HCPs indicated that they aim to strike a balance between the reality 
of the situation, worrying the parents unnecessarily, and setting them at 
ease and therefore try to keep information simple and spread out over 
the day.
Waiting for a confirmatory diagnosis
The period of waiting for confirmatory results was reported to vary 
between hours to a week depending on the condition and treatment 
protocol. For some conditions families will go home as a day case to 
await confirmatory results. For others (e.g. LCHADD) children were 
admitted to the ward. HCPs noted that this can be difficult for the 
parents, but gives the clinicians the opportunity to spend time with the 
family, explain the condition and help with dietary management whilst 
monitoring the child.
HCPs felt that the nature of the symptoms (e.g. sleepiness, vomiting) 
for some ENBS conditions can be hard to assess in a newborn which 
can lead to parental anxiety and trips to hospital during this period. 
Waiting for confirmatory results was acknowledged as difficult by 
HCPs, but considered better managed when parents are reassured and 
have the information they need.
Parents reported that waiting for confirmatory results was stressful. 
They believed that the hospital had tried to turn the result around as 
quickly as possible:
“..think they did it as quickly as they could so that was 
quite reassuring cos it was ...you just want to know don’t 
you so they were quite good like that so yeah they did it 
as quickly as they could, I don’t think they could have 
done much better than they did”. (P8 L479–482).
Whilst waiting, some parents focused on the screening result being 
inaccurate, others assumed the worst case scenario:
“And I was like wow you’ve pretty much confirmed that 
she’s got it, but to say you know 99% but we have to do 
another one to set it to stone to confirm it properly… but 
then I kept holding on to that 1% thinking there’s still 
that chance”.(P2: L185–187.
“No, cause when you’re finding out that your baby can 
end up like a flower and not moving at all, have brain 
damage and I don’t think anybody would be not 
stressed.” (P3: L311–2).
Some parents needed to implement dietary changes during the waiting 
period (condition dependent). The ability to breastfeed and accurate 
dietetics information about this was recalled as important to mothers. 
One mother reported that the stress stopped her from being able to 
breastfeed.
Reaching a diagnosis
HCPs indicated that where possible the news of a confirmatory 
diagnosis was given face to face, and where given on the telephone, the 
parents were called in to discuss. Some parents reported receiving 
results by telephone and some through face to face appointment. The 
parental response to a diagnosis was described by the HCPs as 
individual and variable but often reported to be one of great upset:
“Without a doubt there’s just going to be floods of tears, 
shock and everything” (HCP5: L399).
“…it is bad news you can’t pretend it’s not you know for 
families, you’re telling them that their child has a 
lifelong condition that requires management.” 
(HCP3;L265–7).
There was less detail recalled by parents about the relaying of the 
confirmatory diagnosis than the initial call about the screening result:
“So we must have gone four times in the first year but I 
think, I don’t know about getting the diagnosis.” (P8; 
209–10).
The conditions are complex, and parents felt it took time to absorb the 
information that their child’s condition was confirmed:
“It took a long time to absorb it and understand what 
was wrong with her…It was very overwhelming, and just 
like wow, and you know at first I thought oh my gosh this 
is awful” (P2: L67–72),
HCPs reported parents asking questions about treatment, how the child 
would be affected, how often they would be seen; alongside concern 
about the future quality of life. Only one parent reported in the 
interview feeling that she was unprepared for the reality of her child’s 
condition. The majority felt they were given appropriate information 
and support and felt reassured once treatment was underway.
HCPs report that they aimed to communicate that the screening and 
confirmatory test result was a good day (not a bad one) as the 
knowledge of the condition would improve child health. They noted 
cases of parental denial of the condition where the child is not visibly 
unwell; or in other cases parents had prepared themselves for the worst 
case scenario.
HCPs were asked about the parental response to a false positive 
screening result. It was typically described as relief. In the majority of 
cases the parents were reported not to make contact again, but some had 
rung for reassurance. The management of the conditions vary and so 
may affect the impact of the false positive on the family. HCP contact 
with these families is not maintained so an ongoing impact may not be 
evident, but it was hoped that long term impact could be moderated 
through the cases being well managed.
The parental sample included two families who had a longer period of 
diagnostic uncertainty. The screening had detected a raised metabolite 
but had not led to diagnosis of a screened for condition. In one case a 
clear diagnosis was still not available to the parents at the time of the 
interview; in the other a mild variant of further condition was 
diagnosed. In both cases the parents were glad the issue has been 
identified through ENBS, explored and the child monitored.
Longer term family impact
Parents’ longer term responses to the diagnosis (as described at the time 
of the interview) varied:
“..but she’s not a normal child, she’s not normal. If she 
was normal I wouldn’t worry as much” (P4: 180–1).
“I am happy that my baby is now normal like other 
children, Her food is different…..I am very happy, the 
whole credit goes to the metabolic team “(P6 L244–6).
One mother explained the conflict between wanting to protect her child 
versus the desire to treat her normally. Another indicated that she found 
it hard to explain to her family what was wrong with the child and why 
she worries.
The parents felt that HCP support since diagnosis was knowledgeable 
and well managed:
“P7: They seemed very knowledgeable….
P8: …I don’t think there was a single ‘oh I’ll have to 
come back to you’ answer to any of our questions, I 
think everything was just answered there and then, like I 
say we were dealing with people that…..” (P7 & 8: L284
–289).
Family support had been important. The challenge of managing 
frequent hospital trips alongside care of other children and employment 
was highlighted. Some mothers had taken over management of the 
child’s condition and family relationships were affected:
“To be very frank, the biggest difference was on my 
personal life. Because what a mum can do, a father can’t 
do. I am to this day doing it for my baby. Other family 
friends, have also been affected, I can’t get out as 
much” (PT6: L209–11).
“.... cos I’m always stressed over her, like I do 
everything for her and I run around her quite a lot (PT4: 
L193-4)”.
Three of the mothers interviewed indicated that their relationships had 
broken down and they linked the demands of having a child living with 
a condition. The diagnosis also raised questions for them around genetic 
carriers within the wider family and the impact on future children.
Information resources and support mechanisms
The approach to communication by clinicians was protocol driven, but 
styles were recognised to vary. HCPs felt that communication and 
interaction with parents during the confirmatory testing period should 
be honest and reassuring, and some felt it was importance to 
demonstrate confidence. The importance of breaking down information 
to meet parental needs and using an interpreter for parents with limited 
English was highlighted by HCPs and non-English speaking parents.
Standard ENBS information sheets, emergency letters, and follow up 
information were used across the centres. The ENBS pilot website 
provided condition specific information as well as videos, and charity 
links etc. Parents generally reported that they received clear and well 
explained information that helped them explain the condition to family 
members:
“yeah, we, you know what, early we had so much 
information on that condition from them and even from 
the website, so all we wanted, we did get the 
information”. (PT1: L216–8).
Some HCPs recommended the website to deter parents from finding 
factually incorrect information online. Others waited to refer to the 
website until a condition was confirmed or warned parents off the 
internet due to the tendency to find ‘worst case scenario’ cases on 
unapproved sites. The majority of parents indicated that they had sought 
out information online.
The screening centres provided direct telephone numbers for support 
and advice from the specialist team. The contact numbers were often 
used by parents once diagnosis was confirmed, and sometimes whilst 
waiting for confirmatory results:
“I felt reassured because as soon as there’s a problem 
we’ve got a number for them to ring them straight away 
you know, any questions or anything we’ve got a direct 
number to them so”. (PT5 L180–20).
The value of support groups was explored. It was felt to be of mixed 
value amongst HCPs depending on the nature and attendees of the 
group. Caution was expressed that larger support groups could lead 
parents to be scared by different experiences. One mother wanted 
support to manage the demands of the condition. An interest was 
expressed in informal 1:1 relationships between families affected in a 
similar ways by the same condition.
Impact of ENBS
Parents felt lucky that they had benefited from the pilot programme and 
were grateful to have been provided the opportunity for early treatment. 
Only one of the interviewed parents found that the uncertainty around 
the condition and its early treatment had led to mistrust in the treatment 
and HCPs.
Parents felt that there is limited awareness of ENBS conditions and a 
need for increased knowledge amongst the public and doctors in local 
hospitals:
“Yeah and even my doctor, my doctors been a doctor for 
30 odd years and the doctor at our local hospital has 
been a doctor for 40 years and they’ve never heard of it 
and I’m thinking I’ve now got to educate you guys (PT2: 
L69-71).”
From the HCP perspective, ENBS has led to new knowledge and earlier 
diagnosis. HCPs reported initially relying on their experience with 
existing screened conditions, but condition specific knowledge and 
approaches developed over the pilot. The learning curve was recognised 
for managing cases as well as communication with the family.
HCPs were asked about the impact of ENBS on themselves. The stress 
and anxiety involved in screening was noted by some HCPs both in 
terms of the emotional management of families but also due to the 
workload implications. A positive screen takes priority which can be 
hard to manage alongside other work demands, given the resources 
needed to reach a diagnosis.
“Even the positives are additional but people say it’s 
not, but the thing is actually it’s hard to even talk to the 
Managers and say it’s an ad-hoc thing, whenever it 
comes positive I have to drop everything” (HCP5: 
L:450).
For true positive screening outcomes, there is a grieving process for the 
parents to be managed; as well as the treatment plan and ongoing 
consultation.
Discussion
The expansion of screening to include additional complex and rare 
conditions presents challenges in terms of providing accessible 
information to parents, and communicating results effectively through 
sensitive and supportive interactions with HCPs. This study explored 
parental and HCP experiences of the UK ENBS pilot with a focus on 
the period of confirmatory testing following a positive screening result. 
The views of the parents and HCPs tended to be in alignment raising 
similar issues of concern.
Awareness of the ENBS conditions was reported to be low amongst 
parents prior to receiving the screening results. Given the careful design 
of the ENBS information and consent model prior to the pilot [6], it is 
likely that parents did receive information and were explained the 
nature of the pilot. However, in line with previous research they may 
not have fully attended to, or retained the condition specific information 
provided [29, 28, 30]. As providing adequate information for rare and 
complex conditions continues to be a challenge, it is argued that co-
design [3130, 30] of paper-based and online information with parents 
may further enhance the accessibility of the key messages. Broader 
awareness raising of ENBS conditions amongst the public and wider 
HCP community may also be useful to aid parental and wider family 
understanding.
The first contact, often by telephone, with parents following a positive 
screening result leads to anxiety and lasting memories for parents whilst 
being acknowledged as particularly difficult by HCPs. The content of 
the information provided ahead of a face to face meeting warrants 
further consideration, particularly in areas of the country where there 
may be a delay before direct contact with a specialist. Communication 
scripts co-developed with parents and HCPs are suggested as a possible 
means to guiding the first contact.
The rapid availability of reliable and accessible condition specific 
information as well as support from HCPs and family is important. In 
line with the literature, participants’ views suggested that early direct 
contact between the specialist team and the family and continued 
support, is likely to affect the long-term impact on the family [21, 
3231]. Parents clearly have a desire to seek information online and the 
availability of credible, reliable resources that reflect the early detection 
of conditions and discourage parents from accessing negative images 
and case studies is important. Condition specific information can be 
overwhelming and hard to process at a time of high anxiety for parents, 
so content should be simple, clear and actionable and where possible 
tailored to individual needs. The presence of an independent translator 
where required to ensure that information can be processed and 
responded to by the parent is an imperative.
The increase in positive screening results (both true and false positives) 
through ENBS, places a new and different workload on HCPs and the 
healthcare system. There was variation evident during the pilot due to 
local resources and circumstances that affected parental experience. It is 
important to consider how a consistent approach and service can be 
offered to embed evidence-based guidelines and protocols whilst taking 
into account local context and resources. An assessment of the resource 
implications of the confirmatory testing period alongside adaptable 
workload models and scheduling to cater for the management of screen 
positive cases is needed to support the HCPs involved.
HCPs drew attention to the need to rapidly develop healthcare 
knowledge to manage early detection of the ENBS conditions as well as 
to effectively communicate with and support families. The availability 
of online toolkits to support clinical knowledge development, and offer 
a self-management resource for parents that provides condition specific 
information and support from screening through to ongoing condition 
management may be mechanisms to help support cost-effective 
delivery.
Study limitations and future research
The participant sample in this study was relatively small due to the 
inclusion criteria and challenge of recruitment. However, the interviews 
benefitted from an in-depth reflection on experiences and the HCPs 
interviewed could reflect on multiple cases that they had been 
associated with. Within the parental sample, participants’ children had 
been affected by different conditions, treated at different centres and 
received different diagnoses. Cases will have been managed differently; 
however, it is argued that it is this variability that is of interest.
The time elapsed between receipt of the screening result and the 
interview means the data is reliant on recollection. However, it also 
reflects the longer-term view of the parents and the impact on them. It 
provides a useful collection of views about the emotional response to 
the experience, although it is accepted that factual data about 
information provided e.g. time frames form parents may not be 
accurate.
Men are under-represented in research of this nature. Fathers would 
often be on paternity leave at the time of receiving the screening result; 
but accessing men for the interviews sometime later proved difficult. 
Given the impact on family relationships and employability, their 
continued involvement in screening research is particularly important.
The study highlighted varying responses to the diagnostic experience. 
Future research is needed into the factors affecting diagnostic 
acceptance and the impact of clinical interactions on the long-term 
family response to managing the conditions. As understanding increases 
of the impact of screening and managing a child’s IMD, it would be 
valuable to explore psychological interventions to guide parents 
bonding and maintaining family relationships to help families to 
address the daily challenges they may face.
Conclusions
This study sought to understand and learn from participants’ 
experiences of an ENBS pilot in the UK. With further expansion of the 
number of conditions for which screening can be undertaken and the 
increased rate of false positive results observed in some of the newly 
included disorders, it is timely to consider how the impact of positive 
screening results can be minimised. Although there are studies 
exploring the impact of receiving positive NBS results, many focus on 
quantifying the impact rather than detailed exploration of experiences.
This qualitative study of experiences has highlighted elements within 
the path through confirmatory testing that are difficult for parents and 
could be further developed to benefit the family experience. In 
particularly, the findings recognise there is a need to further develop the 
information given and the mechanisms by which parents are 
communicated with and supported. Recommendations have been made 
to address some of the challenges raised by participants in order to 
further minimise the impact on families of positive screening results.
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